Drug Profile
PD 142505
Latest Information Update: 17 Jan 2007
Price :
$50
*
At a glance
- Originator Pfizer
- Class Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 16 Nov 2000 No-Development-Reported for Alzheimer's disease in USA (Unknown route)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 01 Jun 1995 Preclinical development for Alzheimer's disease in USA (Unknown route)